Elsevier

Peptides

Volume 26, Issue 12, December 2005, Pages 2500-2504
Peptides

Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients

https://doi.org/10.1016/j.peptides.2005.04.019Get rights and content

Abstract

Vasopressin is one of the key regulators of the body's water and solute balance. When this balance is pathologically disturbed, determination of serum vasopressin concentrations might be a helpful tool for guiding therapy. However, due to its instability and considerable association to platelets, reliable measurement of circulating vasopressin is difficult to achieve, if at all. In search of a more robust way for quantifying vasopressin release, we identified copeptin, a glycopeptide with unknown function, as an alternative diagnostic target. Since copeptin is derived from the same precursor peptide as vasopressin, released amounts of copeptin should mirror those of vasopressin. With a newly developed sensitive sandwich immunoassay, we detected strongly elevated concentrations of fully processed copeptin in serum of septic shock patients. The magnitude of elevation and the high stability of copeptin in serum and plasma indicate that copeptin measurement is not affected by the problems, which are associated with the direct measurement of vasopressin, and thus is apparently suitable to indirectly determine the release of vasopressin.

Introduction

Vasopressin (also known as antidiuretic hormone) is a nonapeptide, which is released from the neurohypophysis into the bloodstream in order to promote water conservation by the kidney, and thereby contributes to the regulation of osmotic and cardiovascular homeostasis [23]. Recently, vasopressin has been investigated as a supplementary vasopressor agent in the treatment of septic shock, where endogenous levels of vasopressin apparently decline during the progression of shock [15], [18]. The measurement of endogenous vasopressin levels in plasma could be a useful tool to guide therapy in pathologies where osmotic and cardiovascular homeostasis are dysregulated [20]. However, serious concerns exist about the methodologic reliability of plasma vasopressin measurement, because vasopressin is known to be unstable, largely attached to platelets and rapidly cleared [11], [19], [21].

Vasopressin is derived from a larger precursor peptide along with two other peptides, neurophysin II and copeptin (Fig. 1) [7]. Neurophysin II has a complex structure and is associated with vasopressin, at least under acidic conditions [17]. Copeptin is a 39 amino acid glycopeptide of unknown function in the circulation [9], [24].

Here, we report on the immunometric quantification of copeptin in human serum and plasma as an alternative to direct vasopressin measurement. Since copeptin is initially produced in equimolar amounts to vasopressin, released amounts of copeptin should represent those of vasopressin.

Section snippets

Chemicals

If not stated otherwise, chemicals were obtained at p.a. grade from Merck, Darmstadt, Germany. Bovine serum albumin and unspecific sheep IgG were from SIGMA, Deisenhofen, Germany.

Peptides

Three peptides related to copeptin were chemically synthesized, purified, and quality-controled by standard procedures (JERINI AG, Berlin, Germany). The peptides were: PATV17 (sequence CATQLDGPAGALLLRLV, representing positions 132–147 of pre-pro-vasopressin plus an N-terminal cystein residue), PLAY17 (sequence

Results

For the generation of anti-copeptin antibodies, two 17mer peptides were deduced from the copeptin sequence as immunogens, which are located C-terminal to the asparagine residue at position 132, which has been reported to be glycosylated, at least in copeptin from pig, ox, and sheep extracted from the neurohypophysis [8], [24]. Using these antibodies, a one-step sandwich immunoassay for the detection of copeptin was developed, employing the chemiluminescence-label and coated tube-technique. The

Discussion

Using a newly developed sandwich immunoassay for copeptin, a peptide derived from the vasopressin precursor, we present three major findings in this study: first, plasma levels of copeptin are strongly elevated in septic shock patients as compared to healthy controls. Second, copeptin is very stable in plasma and serum. Third, serum copeptin of septic shock patients is glycosylated and is quantitatively cleaved off from the vasopressin precursor.

For a number of reasons, the measurement of

Acknowledgements

We wish to thank Dr. Martina Strebelow and Sonja Tietz (LAD GmbH), Dr. Cornelia Lenzner and Sandra Müller (Bioassays GmbH), and Chen Tao (B·R·A·H·M·S Aktiengesellschaft) for excellent technical assistance.

References (26)

  • F.M. de Bree et al.

    Structure–function relationships of the vasopressin prohormone domains

    Cell Mol Neurobiol

    (1998)
  • D.A. Holwerda

    A glycopeptide from the posterior lobe of pig pituitaries. 2. Primary structure

    Eur J Biochem

    (1972)
  • D.A. Holwerda

    A glycopeptide from the posterior lobe of pig pituitaries. I. Isolation and characterization

    Eur J Biochem

    (1972)
  • Cited by (209)

    • Copeptin in fluid disorders and stress

      2022, Clinica Chimica Acta
    • Development of a sensitive liquid chromatography-tandem mass spectrometry method for quantification of human plasma arginine vasopressin

      2021, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
    • Vasopressin and copeptin release during sepsis and septic shock

      2021, Peptides
      Citation Excerpt :

      Table 2). In a historical context, Struck et al. in 2005 demonstrated elevated concentrations of copeptin in septic shock patients [14,16]. Later, Morgenthaler et al., [38,40] also was described increased copeptin levels in patients with sepsis.

    View all citing articles on Scopus
    View full text